· Periodic Report
Q3 revenue KRW 24.7 billion, operating profit KRW 2.0 billion, net loss KRW 1.4 billion
Metabiomed sold KRW 24.7 billion in Q3 and earned KRW 2.0 billion from its main business, down 60.9% from a year earlier and down 68.3% from the previous quarter.